Suvorexant

Insomnia Treatment: Safety, Efficacy of Suvorexant Drug in Women with Night Sweats and Hot Flashes Investigated

Medicine & Technology Feb 18, 2022

Through a randomized, double-blind, placebo-controlled clinical trial, researchers at Brigham and Women's Hospital discovered that the insomnia drug suvorexant developed by Merck & Co., was safe and effective, improving insomnia and night sweats in peri- and postmenopausal women.

Suvorexant

Insomnia Treatment: Safety, Efficacy of Suvorexant Drug in Women with Night Sweats and Hot Flashes Investigated

Most Popular

Cave of Death in Costa Rica Appears Harmless but Can Instantly Kill Anyone at the Entrance

White Hair Explained: Here's Why It Can't Go Back to Its Original Color if the Cause Is Genetic

Motherhood Changes You: Here's How Being a Mom Affects Your Body, Biology

Space Weather Alert: NOAA Warns of a Solar Radiation Storm With 60% Chance of Hitting the Earth This Week

Solar Storm Alert: Rare Cosmic Event, First in 20 Years, Threatens Earth's Tech

Recommended Stories

Powerful Solar Storm Lights Up Skies for 2 Nights in a Row Over the Weekend Without Major Power Disruptions

James Webb Space Telescope Finds Distinct Carbon-Rich Atmosphere Around '55 Cancri E' Exoplanet

Fastest Spinning Space Rock on Record? Asteroid 2024 BX1 That Blasted Over Berlin Had the Fastest Spin Among Near-Earth Objects

Sunspot Region AR3664 Has Grown 15 Times the Earth’s Diameter As It Releases Powerful Solar Flares, Might Be Visible Using Eclipse Glasses